Increased levels of lipoprotein (a) in Crohn's disease: A relation to thrombosis?

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 12, 2001, Pages 1415-1419

  Koutroubakis, Ioannis E ^a   Malliaraki, Niki ^a   Vardas, Emmanouel ^a   Ganotakis, Emmanouel ^a   Margioris, Andreas N ^a   Manousos, Orestes N ^a   Kouroumalis, Elias A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Crohn's disease; Lipids; Lipoprotein (a); Thrombosis; Ulcerative colitis

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN; TRIACYLGLYCEROL;

ADULT; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; ULCERATIVE COLITIS; VEIN THROMBOSIS;

ADULT; APOLIPOPROTEINS; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GREECE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM;

EID: 0035216261     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200112000-00004     Document Type: Article

References (38)

1. Vascular complications of inflammatory bowel disease
2. Thromboembolism in inflammatory bowel disease: Role of platelets
3. Review article: Platelets in inflammatory bowel disease - Pathogenetic role and therapeutic implications
4. Venous thrombosis occurring in non-specific ulcerative colitis
5. Role of thrombosis in inflammatory bowel disease
6. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
7. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases
8. Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements
9. Circulating von Willebrand factor in inflammatory bowel disease
10. Thrombotic vascular risk factors in inflammatory bowel disease
11. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease
12. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease
13. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications
14. Hyperhomocysteinemia in Greek patients with inflamma tory bowel disease
15. Prevalence and significance of anticardiolipin antibodies in Crohn's disease
16. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease
17. The role of lecithin: Cholesterol acyltransferase for lipoprotein(a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma
18. cDNA sequence of human lipoprotein (a) is homologous to plasminogen
19. High lipoprotein (a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism
20. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease
21. Dahlen GH, Lp(a) lipoprotein in cardiovascular disease
22. Lipoprotein (a): From ascestral benefit to modern pathogen?
23. Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome
24. Transient changes of serum lipoprotein (a) as an acute phase protein
25. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease
26. Altered lipid profile, lipoprotein composition, oxidant and antioxidant status in pediatric Crohn disease
27. Classification of inflammatory bowel disease
28. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
29. A simple clinical colitis activity index
30. Serum lipoprotein(a) levels in a Greek population sample without history of premature myocardial infarction
31. Pathogenesis of Crohn's disease; multifocal gastrointestinal infarction
32. Paradoxical response to heparin in 10 patients with ulcerative colitis
33. Inherited disorders of coagulation appear to protect against inflammatory bowel disease
34. Lipoprotein(a), fibrin binding, and plasminogen activation
35. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism
36. Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain
37. HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease
38. Glycocorticoid therapy decreases serum lipoprotein (a) concentration in rheumatic diseases